Investor Presentaiton

Q3 2023 Financial Highlights Revenue $71m 56% YoY reported growth 26% pro forma(1) YoY growth Trailing 12 Month Revenue $216m ~54% from Medical Short Distance YoY Revenue Growth 49% MediMobility Organ Transport YoY Revenue Growth 65% Flight Margin 22% Up 150 bps YoY Adjusted EBITDA $1mm Note: Definition of all non-GAAP numbers and reconciliation to GAAP numbers are provided in the Appendix of this presentation 1. Pro forma growth reflects revenue growth as if Blade had owned the charter and scheduled air mobility businesses of Monacair, Héli Sécurité and Azur Hélicoptère in the prior year period BLADE 22 222

View entire presentation